Mar 17, 2026 10:12AM
Dec 5, 2025 02:58AM
Nov 5, 2025 12:17PM
Oct 27, 2025 07:05PM
Oct 27, 2025 07:05PM
Oct 24, 2025 12:38AM
Oct 24, 2025 12:37AM X4 Pharmaceuticals Announces Pricing of $135 Million Underwritten Public Offering
Oct 23, 2025 04:01PM
Oct 23, 2025 04:01PM
Aug 29, 2025 07:17AM
Aug 12, 2025 07:01AM
Aug 12, 2025 07:00AM
Mar 25, 2025 02:25PM
Nov 14, 2024 08:00AM X4 Pharmaceuticals to Participate in the Stifel 2024 Healthcare Conference
Nov 13, 2024 04:00PM
Jun 27, 2024 03:49PM
Nov 10, 2023 08:00AM
May 16, 2023 08:31AM
May 16, 2023 08:30AM
May 15, 2023 09:10AM
May 15, 2023 09:08AM Weekly biotech pulse: X4 Pharma data on deck, AbbVie set for FDA review
Dec 7, 2022 08:43AM
Dec 7, 2022 08:43AM
Dec 7, 2022 06:19AM
Dec 6, 2022 06:26PM
Nov 8, 2022 08:00AM
Jul 1, 2022 05:49AM
Jun 30, 2022 07:52PM X4 Pharmaceuticals Announces $55 Million Private Placement Financing and Debt Facility Amendment Extending Interest-Only Period by up to 12 Months
Mar 17, 2022 12:43PM
Nov 10, 2021 08:00AM
Mar 19, 2021 08:04AM
Mar 19, 2021 08:01AM
Mar 5, 2021 06:13AM
Nov 10, 2020 08:00AM
Nov 5, 2020 03:44PM X4 Pharmaceuticals (XFOR) PT Lowered to $20 at Stifel, Following Earnings
Nov 26, 2019 08:31AM
Nov 26, 2019 08:30AM
Nov 25, 2019 04:01PM
Nov 25, 2019 04:00PM
Nov 15, 2019 08:30AM
Jun 7, 2019 01:54AM
Apr 12, 2019 09:33AM X4 Pharmaceuticals (XFOR) Prices 5.7M Shares at $11 w/Warrants
Apr 12, 2019 09:29AM
Apr 11, 2019 04:01PM
Apr 11, 2019 04:00PM

42,966 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All